The MD (Pathology) at Sardar Patel Medical College (SPMC), Bikaner is a 3-year postgraduate medical degree programme affiliated with the Rajasthan University of Health Sciences (RUHS). The course provides comprehensive training in histopathology, cytopathology, haematology, clinical pathology, and autopsy pathology, with access to well-equipped pathology laboratories and the diagnostic resources of the attached PBM Hospital. The total academic fees for the programme are INR 46,855 (government quota), with 10 seats available in the Pathology department. Admission is based on NEET PG scores followed by MCC/Rajasthan state counselling. MD Pathology is a para-clinical speciality that is popular among candidates interested in laboratory medicine, histopathology, and academic careers in medical colleges, with growing demand in both government and private diagnostic sectors.
Admission for the 2026 academic session is currently ongoing. The NEET PG Round 1 allotment result was declared on March 18, 2026, and reporting to the allotted institute is ongoing till March 25, 2026. Round 2 counselling registration and fee payment is scheduled from March 28 to April 3, 2026, with the academic session commencing on April 10, 2026. For NEET PG 2026 (next cycle), the exam is tentatively scheduled for August 30, 2026.
Key Points
- MD Pathology at SPMC Bikaner has 10 seats, filled through MCC (All India Quota) and Rajasthan state counselling.
- The course is a para-clinical speciality with strong demand in diagnostic laboratories, hospitals, and academic institutions.
- SPMC Bikaner is affiliated with RUHS and is one of the top government medical colleges in Rajasthan.
- The Pathology department at SPMC handles a large volume of histopathology, cytopathology, and haematology specimens from PBM Hospital.
- The programme is offered under government quota only; there are no management or NRI quota seats.
- Graduates are eligible for faculty positions in medical colleges and roles in diagnostic pathology, forensic pathology, and research.
Comments